Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

TGF-β is found in hair follicles and may cause hair loss in alopecia areata.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The dog had sebaceous adenitis, treated with ciclosporin, leading to some hair regrowth.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

Tight hairstyles can cause temporary or permanent hair loss, with less hair seen under a microscope in later stages.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

TNF-alpha inhibitors can cause various immune-related skin issues.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.